2.41
price down icon18.31%   -0.54
after-market Handel nachbörslich: 2.46 0.05 +2.07%
loading

Milestone Pharmaceuticals Inc Aktie (MIST) Neueste Nachrichten

pulisher
08:02 AM

Milestone (NASDAQ: MIST) gains FDA approval for self-use CARDAMYST PSVT spray - Stock Titan

08:02 AM
pulisher
08:00 AM

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) - GlobeNewswire Inc.

08:00 AM
pulisher
10:13 AM

Rocket Lab (RKLB) Stock News Today: Neutron “Hungry Hippo” Milestone, Launch Updates, and Analyst Forecasts (Dec. 12, 2025) - ts2.tech

10:13 AM
pulisher
Dec 11, 2025

Milestone Pharmaceuticals Eyes FDA Approval Amid Strong Q3 Results - timothysykes.com

Dec 11, 2025
pulisher
Dec 09, 2025

A new trading data show Milestone Pharmaceuticals Inc (MIST) is showing positive returns. - setenews.com

Dec 09, 2025
pulisher
Dec 05, 2025

Is Milestone Pharmaceuticals Inc. stock recession proofDip Buying & Long-Term Growth Stock Strategies - Newser

Dec 05, 2025
pulisher
Dec 02, 2025

Milestone Pharmaceuticals (Nasdaq: MIST) issues 30,000 options at $2.69 under 2021 Inducement Plan - Stock Titan

Dec 02, 2025
pulisher
Dec 02, 2025

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 02, 2025
pulisher
Dec 02, 2025

Stock Traders Purchase Large Volume of Call Options on Milestone Pharmaceuticals (NASDAQ:MIST) - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

EV Market: Will Milestone Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 Momentum & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ

Dec 02, 2025
pulisher
Dec 02, 2025

Milestone Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:MIST) - Defense World

Dec 02, 2025
pulisher
Dec 01, 2025

Milestone Pharmaceuticals Inc (MIST) Performance and Fundamentals Dashboard tells a completely different story - Setenews

Dec 01, 2025
pulisher
Nov 26, 2025

Will Milestone Pharmaceuticals Inc. stock gain from lower inflation2025 Volatility Report & AI Enhanced Trading Alerts - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 25, 2025

Healthy Upside Potential: Milestone Pharmaceuticals Inc (MIST) - setenews.com

Nov 25, 2025
pulisher
Nov 25, 2025

Jefferies Lifts Milestone Pharmaceuticals (MIST) Price Targets on Product Sales Prospects - Insider Monkey

Nov 25, 2025
pulisher
Nov 25, 2025

Local Pharmaceutical Company Earns $200 Million Milestone Payment in Sarepta Partnership - Pasadena Now

Nov 25, 2025
pulisher
Nov 25, 2025

Grasim Industries Limited Trading Near Value Zone Recovery AheadRetail Investor Activity & Low Entry Risk Stocks - earlytimes.in

Nov 25, 2025
pulisher
Nov 24, 2025

13 Best Canadian Penny Stocks to Buy Right Now - Insider Monkey

Nov 24, 2025
pulisher
Nov 24, 2025

Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics - Business Wire

Nov 24, 2025
pulisher
Nov 23, 2025

Milestone Pharmaceuticals (NASDAQ:MIST) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Nov 23, 2025
pulisher
Nov 22, 2025

Milestone Pharmaceuticals Prepares for CARDAMYST Launch Amid Financial Growth - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

Milestone Pharmaceuticals Inc. (MIST) stock price, news, quote and history - Yahoo Finance UK

Nov 21, 2025
pulisher
Nov 21, 2025

Milestone Pharmaceuticals Inc. (MIST) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 21, 2025
pulisher
Nov 21, 2025

Is Milestone Pharmaceuticals Inc. stock bottoming outJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How analysts rate Milestone Pharmaceuticals Inc. stock today2025 Market Trends & Daily Oversold Bounce Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Published on: 2025-11-20 02:01:48 - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Milestone Pharmaceuticals Inc. recover in the next quarter2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 17:33:54 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts remain bullish on Milestone Pharmaceuticals Inc. stockJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 13:39:11 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

It makes sense and dollars to buy Milestone Pharmaceuticals Inc (MIST) stock - Setenews

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 06:17:41 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using Bollinger Bands to evaluate Milestone Pharmaceuticals Inc.Weekly Volume Report & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Milestone Pharmaceuticals Inc. stock reacts to oil pricesTreasury Yields & Daily Market Momentum Tracking - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

How to forecast Milestone Pharmaceuticals Inc. trends using time series2025 Year in Review & Stock Portfolio Risk Control - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Could Be 44% Below Their Intrinsic Value Estimate - Yahoo Finance

Nov 18, 2025
pulisher
Nov 17, 2025

What is HC Wainwright's Estimate for MIST FY2025 Earnings? - MarketBeat

Nov 17, 2025
pulisher
Nov 17, 2025

What is HC Wainwright’s Estimate for MIST FY2025 Earnings? - Defense World

Nov 17, 2025
pulisher
Nov 16, 2025

Will Milestone Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Volume Leaders & Weekly Momentum Picks - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can Milestone Pharmaceuticals Inc. stock resist sector downturns2025 Price Momentum & Expert Approved Trade Ideas - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Is it too late to sell Milestone Pharmaceuticals Inc.Weekly Stock Report & Safe Swing Trade Setups - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Does Milestone Pharmaceuticals (NASDAQ:MIST) Have A Healthy Balance Sheet? - simplywall.st

Nov 15, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):